Boston Sci’s Wingspan Gets Limited Nat’l Coverage; Broad HDE Policy Will Wait

Medicare will nationally cover intracranial stenting and angioplasty only in the controlled setting of FDA-cleared clinical trials, CMS says

More from Archive

More from Medtech Insight